Saturn Partners
Saturn Data Room
Navigate
  • Team
  • Portfolio
  • Entrepreneurs
  • News
  • Regulatory
    • Client Relationship Summary
    • FINRA Broker Check
    • Patriot Act Notice

Monthly Archives: November 2017

YieldStreet Hits $200 Million in Originations Milestone & Appoints Two New Members to Leadership Team

Posted on November 27, 2017 at 11:09 am.

Written by saturnadmin

YieldStreet, an online marketplace for a diverse array of asset-backed investments, recently announced it has surpassed $200 million in originations. This news comes just six months after the investment platform achieved its $100 million in origination milestone. As previously reported, YieldStreet … Continued

YieldStreet Surpasses $200M in Originations, Bolsters Leadership Team and Launches New Website amid Period of High Growth

Posted on November 20, 2017 at 10:00 am.

Written by saturnadmin

BUSINESS WIRE- NEW YORK–(BUSINESS WIRE)–YieldStreet, the alternative investment platform that is working to change the way wealth is created, announced that it has surpassed $200 million in originations and has added two new executives to its leadership team: Volfi Mizrahi … Continued

YieldStreet : Surpasses $200M in Originations, Bolsters Leadership Team and Launches New Website amid Period of High Growth

Posted on November 16, 2017 at 9:21 am.

Written by saturnadmin

11/15/2017 | 04:02pm CET Appoints Volfi Mizrahi as Managing Director of Originations and Ivor Wolk as General Counsel YieldStreet, the alternative investment platform that is working to change the way wealth is created, announced that it has surpassed $200 million … Continued

Recent Posts

  • Areteia Therapeutics Announces Additional $75MM in Series A Financing for Oral Dexpramipexole in Eosinophilic Asthma
  • Yieldstreet to acquire real estate tech startup Cadre
  • Biohaven Reports Positive Data From EEG Biomarker Study Of BHV-7000
  • Agri-Nutrients SABIC cooperates with American companies to support sustainable farming
  • Areteia Therapeutics Announces Publication of Phase II Data of Oral Dexpramipexole in Eosinophilic Asthma

Archives

  • February 2024
  • December 2023
  • September 2023
  • August 2023
  • July 2023
  • May 2023
  • March 2023
  • December 2022
  • July 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • September 2021
  • June 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • July 2020
  • June 2020
  • February 2020
  • January 2020
  • December 2019
  • October 2019
  • September 2019
  • August 2019
  • April 2019
  • March 2019
  • January 2019
  • December 2018
  • August 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • June 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • May 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • October 2012

Categories

  • Fund
  • Industry
  • Personal
  • Portfolio

617-574-3330

[email protected]

© 2025 Saturn Partners. All rights reserved.

Site Map | Terms of Use